Cramer Rosenthal McGlynn’s Agilysys AGYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,862
Closed -$2.82M 98
2024
Q3
$2.82M Sell
25,862
-46,684
-64% -$4.99M 0.16% 90
2024
Q2
$7.55M Sell
72,546
-19,827
-21% -$1.78M 0.44% 76
2024
Q1
$7.78M Sell
92,373
-33,762
-27% -$2.73M 0.42% 71
2023
Q4
$10.7M Sell
126,135
-45,010
-26% -$3.65M 0.58% 64
2023
Q3
$11.3M Buy
171,145
+20,319
+13% +$1.41M 0.63% 61
2023
Q2
$10.4M Buy
150,826
+13,501
+10% +$1.02M 0.52% 69
2023
Q1
$11.3M Sell
137,325
-121,875
-47% -$9.85M 0.51% 73
2022
Q4
$20.5M Sell
259,200
-143,208
-36% -$9.13M 0.9% 48
2022
Q3
$22.3M Sell
402,408
-12,316
-3% -$621K 1.07% 41
2022
Q2
$19.6M Sell
414,724
-82,499
-17% -$3.21M 0.9% 48
2022
Q1
$19.8M Sell
497,223
-18,825
-4% -$756K 0.77% 56
2021
Q4
$22.9M Buy
516,048
+197,655
+62% +$9.39M 0.74% 58
2021
Q3
$16.7M Buy
318,393
+3,253
+1% +$178K 0.57% 66
2021
Q2
$17.9M Buy
315,140
+95,168
+43% +$4.92M 0.57% 70
2021
Q1
$10.6M Sell
219,972
-318,949
-59% -$15.9M 0.35% 78
2020
Q4
$20.7M Buy
538,921
+11,675
+2% +$388K 0.65% 51
2020
Q3
$12.7M Buy
+527,246
New +$11.7M 0.51% 70

Other funds holding AGYS

Cramer Rosenthal McGlynn's AGYS Position: Q4 2024 in Review

Cramer Rosenthal McGlynn sold out of Agilysys (AGYS) in Q4 2024, closing a stake of 25,862 shares — an estimated $2.82M sold.

Cramer Rosenthal McGlynn first reported a position in AGYS in Q3 2020 and held it in 17 quarters. The position peaked at $22.9M in Q4 2021. 270 funds tracked by Wall St. Rank hold AGYS as of Q4 2024.

  • Cramer Rosenthal McGlynn reported no remaining Agilysys position as of Q4 2024 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 25,862 Agilysys shares in Q4 2024, an estimated $2.82M.
  • Cramer Rosenthal McGlynn first reported a position in Agilysys in Q3 2020 and held it in 17 quarters.
  • Cramer Rosenthal McGlynn's Agilysys position peaked at $22.9M in Q4 2021.
  • 270 funds tracked by Wall St. Rank held Agilysys as of Q4 2024.

Based on Cramer Rosenthal McGlynn's 13F filing for Q4 2024, filed 13 Feb 2025.